Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling

Journal of Molecular and Cellular Cardiology

Volumn 91, Issue , 2016, Pages 134-140

  Lindsey, Merry L ^a,b   Iyer, Rugmani Padmanabhan ^a   Jung, Mira ^a   DeLeon Pennell, Kristine Y ^a   Ma, Yonggang ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Extracellular matridomics; Extracellular matrix; MMP; Proteomics; Signaling; Systems biology

Indexed keywords

MATRIX METALLOPROTEINASE; CYTOKINE; ISOENZYME; SCLEROPROTEIN;

DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEGRADATION; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CARDIAC MUSCLE; CHEMISTRY; COMPLICATION; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HEART FAILURE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEOMICS; WOUND HEALING;

ANIMALS; CYTOKINES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; ISOENZYMES; MATRIX METALLOPROTEINASES; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEOMICS; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING; WOUND HEALING;

EID: 84953433030     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.12.018     Document Type: Review

References (10)

1. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., et al. Heart disease and stroke statistics-2015 update: a report from the American heart association. Circulation 2015, 131:e29-322.
2. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American heart association. Circulation 2011, 123:e18-e209.
3. Solomon S.D., Sutton M.S.J., Lamas G.A., Plappert T., Rouleau J.L., Skali H., et al. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation 2002, 106:1251-1255.
4. Lavine S.J. Prediction of heart failure post myocardial infarction: comparison of ejection fraction, transmitral filling parameters, and the index of myocardial performance. Echocardiography 2003, 20:691-701.
5. Hellermann J.P., Jacobsen S.J., Redfield M.M., Reeder G.S., Weston S.A., Roger V.L. Heart failure after myocardial infarction: clinical presentation and survival. Eur. J. Heart Fail. 2005, 7:119-125.
6. Hellermann J.P., Goraya T.Y., Jacobsen S.J., Weston S.A., Reeder G.S., Gersh B.J., et al. Incidence of heart failure after myocardial infarction: is it changing over time?. Am. J. Epidemiol. 2003, 157:1101-1107.
7. Anavekar N.S., McMurray J.J.V., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.-L., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 2004, 351:1285-1295.
8. Sutton M.S.J., Pfeffer M.A., Moye L., Plappert T., Rouleau J.L., Lamas G., et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the survival and ventricular enlargement (SAVE) trial. Circulation 1997, 96:3294-3299.
9. Ezekowitz J.A., Kaul P., Bakal J.A., Armstrong P.W., Welsh R.C., McAlister F.A. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J. Am. Coll. Cardiol. 2009, 53:13-20.
10. Wells J.M., Gaggar A., Blalock J.E. MMP generated matrikines. Matrix Biol. May-Jul 2015, 44-46:122-129.